Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’m hardly a chameleon, my friend: I’m a TOUGH AND DEMANDING shareholder. All I needed was to see definitive signs of life—we got that yesterday and today, in my opinion.
3.4M shares locked GTC at $20 PPS
Got another 600K
I snagged another 2M yesterday—something was VERY different about that trading action....
Do you have any idea how much of a lift it would be to raise this to even $1 PPS with, say, 2B OS? When we rose to .07, the OS was around 600M—and the anticipated business model hasn’t really changed. I love the idea of preventing a hostile takeover, but I’m more interested in PPS (naturally). What am I missing here?
Has CELZ ever had another day with 250M traded?
2.775 milly club and pondering more. Is it FINALLY happening?
Why did it ever go DOWN by 98%?
It was at .07 over a year ago with roughly half the OS. Where’s the logic in THAT??
Don’t tell me this is going back to .01. UNIMPRESSED. No rational explanation to the questions I have been asking for over a year has yet been proffered. This leaves only the conclusion that this operates irrationally (and also quite randomly). Rule #1 in human relationships: “When someone shows you their true self, BELIEVE THEM.”
Lmao. I highly doubt it. This thing is DEAD
Take a number. I’ve been beating the same drum for 1.5 years. Most illogical, counterintuitive thing I have EVER seen
I’ll play along. Please explain the following:
Down 98% since 2018, even as revs have INCREASED—precisely the OPPOSITE of the direction PPS should be going in. This week will mark one YEAR since trial concluded—and still no publication.
Training of docs on CaverStem/FemCelz continues at a GLACIAL pace: according to my best reckoning of the revs vs. COGS, under 50 procedures were performed during the entire QUARTER that ended on 6/30/2019. What a farce. Where’s the beef?
Meantime, as of the most recent filing, EPS continues to improved—UP from -.01 to essentially 0. With positive EPS seemingly on the horizon (based on the trend), how CRAZY is it for the current PPS to be mired at 1/10 of one penny? What am I missing in this equation (the financials are what they are)?
Again, I MUST ask this question until it gets answered: whose interest is advanced by having the PPS THIS DAMN LOW? What is
Why is CELZ management allowing our mutual interest to dwindle away to almost nothing?
I’m trying very hard not to laugh at them (and myself) right now: they have done NOTHING to capitalize even fractionally on the immense (though still alleged) potential of CaverStem and FemCelz—and now they wanna muddy the waters by switching focus?!
What AmnioStem “deal”?
So they increased the A/S with the idea in mind of similarly increasing the O/S in the future—in order to avoid a takeover? Wouldn’t it be easier and less dilutive to release the trial results and let the PPS rise to such a level that a takeover would be more costly?
I’m not quite sure what else you want/need to know about the “big 3”—they are listed by name in several filings...
Funny how that post has now been deleted
Down 98% since 2018, even as revs have INCREASED—precisely the OPPOSITE of the direction PPS should be going in. This week will mark one YEAR since trial concluded—and still no publication.
Training of docs on CaverStem/FemCelz continues at a GLACIAL pace: according to my best reckoning of the revs vs. COGS, under 50 procedures were performed during the entire QUARTER that ended on 6/30/2019. What a farce. Where’s the beef?
Meantime, as of the most recent filing, EPS continues to improved—UP from -.01 to essentially 0. With positive EPS seemingly on the horizon (based on the trend), how CRAZY is it for the current PPS to be mired at 1/10 of one penny? What am I missing in this equation (the financials are what they are)?
Again, I MUST ask this question until it gets answered: whose interest is advanced by having the PPS THIS DAMN LOW? What is the logic here?
Keep in mind that the EPS is essentially now flat—UP from -.01. What happens in the next quarter or two if the trend continues and this shows POSITIVE EPS??? It is beyond insane, in this context, for the PPS to be where it is. Please explain.
Nonetheless, those interested parties who “informally” advertised the results LONG ago via various social media platforms are responsible for those communications (many of which have been captured and preserved electronically) and the claims made therein...
I’ve said similar things about many press releases for over a year: embarrassing errors that suggest haste of composition and failure to have proper editorial oversight. Moreover, I emailed them at least twice, respectfully expressing the perspective of an educated and experienced writer (who also happens to be deeply invested in CELZ): CRICKETS. Evidently “they got this”—even when they clearly don’t...
Trial ended one year ago today: CRICKETS
Objectively verifiable: JUSTDAFACTSS! Look ‘em up for yourself.
I don’t buy it: this same group took Medistem from this same range to over $2/share before being bought out for about $1.5/share—and Medistem had NO REVENUES.
Down 98% since 2018, even as revs have INCREASED—precisely the OPPOSITE of the direction PPS should be going in. This week will mark one YEAR since trial concluded—and still no publication.
Training of docs on CaverStem/FemCelz continues at a GLACIAL pace: according to my best reckoning of the revs vs. COGS, under 50 procedures were performed during the entire QUARTER that ended on 6/30/2019. What a farce. Where’s the beef?
Again, I MUST ask this question until it gets answered: whose interest is advanced by having the PPS of a company with revenues and now roughly break even on earnings/share THIS DAMN LOW? What is the logic?
I’m done with this BS
Opportunity struck 1.5 YEARS ago: no more hollow, unsubstantiated BS!!
Those interested parties who “informally” advertised the results LONG ago via various social media platforms are nonetheless responsible for those communications (many of which have been captured and preserved electronically) and the claims made therein...
Down 98% since 2018, even as revs have INCREASED—precisely the OPPOSITE of the direction PPS should be going in. This week will mark one YEAR since trial concluded—and still no publication. Training of docs on CaverStem/FemCelz continues at a GLACIAL pace: according to my best reckoning of the revs vs. COGS, under 50 procedures were performed during the entire QUARTER that ended on 6/30/2019. What a farce. Where’s the beef?
Again, I MUST ask this question until it gets answered: whose interest is advanced by having the PPS of a company with revenues and now roughly break even on earnings/share THIS DAMN LOW? What is the logic?
A real company would have thought that through FIRST, before changing the name to Bantek. Now it looks like they’re just trying to reset the clock—AGAIN...
Down 98% since 2018, even as revs have INCREASED—precisely the OPPOSITE of the direction PPS should be going in. This week will mark one YEAR since trial concluded—and still no publication. Training of docs on CaverStem/FemCelz continues at a GLACIAL pace: according to my best reckoning of the revs vs. COGS, under 50 procedures were performed during the entire QUARTER that ended on 6/30/2019. What a farce. Where’s the beef?
You may cheer when your team, down 60-0, scores a garbage TD or two—I don’t.
Down 98% at mine. A funny thing
is variant perspective...
Still down 98 percent from .07...
No source=didn’t/won’t happen